Emi, Inc, based in Torrance, CA, is a biopharmaceutical company dedicated to improving the lives of individuals through the discovery, development, and commercialization of innovative treatments and therapies. Specializing in rare and orphan diseases such as sickle cell disease, Emi, Inc has expanded its focus to include conditions affecting larger populations like diverticulosis.
With a mission to address unmet medical needs, Emi, Inc has received marketing authorizations for its products in various countries, including Puerto Rico, Oman, and Bahrain. The company's commitment to advancing healthcare is evident through its research, publications, and financial reports that highlight its efforts in providing effective solutions for patients in need.
Generated from the website